Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M94,609Revenue (TTM) $M19,427Net Margin (%)22.9Altman Z-Score6.0
Enterprise Value $M95,137EPS (TTM) $2.7Operating Margin %23.8Piotroski F-Score6
P/E(ttm)21.4Beneish M-Score-2.2Pre-tax Margin (%)30.5Higher ROA y-yY
Price/Book5.810-y EBITDA Growth Rate %-1.1Quick Ratio1.4Cash flow > EarningsN
Price/Sales4.95-y EBITDA Growth Rate %-4.5Current Ratio1.6Lower Leverage y-yY
Price/Free Cash Flow58.2y-y EBITDA Growth Rate %145ROA % (ttm)13.6Higher Current Ratio y-yY
Dividend Yield %2.7PEG--ROE % (ttm)29.6Less Shares Outstanding y-yN
Payout Ratio %58.0Shares Outstanding M1,673ROIC % (ttm)20.9Gross Margin Increase y-yN

Gurus Latest Trades with BMY

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

BMY is held by these investors:



BMY: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
ANDREOTTI LAMBERTODirector 2016-09-08Sell21,600$56.87-0.55view
ANDREOTTI LAMBERTODirector 2016-08-25Sell23,200$59.17-4.41view
ANDREOTTI LAMBERTODirector 2016-07-08Sell23,200$74.45-24.03view
ANDREOTTI LAMBERTODirector 2016-06-28Sell23,200$72.14-21.6view
Elicker John ESVP, Public Affairs & IR 2016-06-14Sell11,820$72.69-22.19view
Bancroft Charles AEVP & CFO 2016-05-20Sell30,201$70.79-20.1view
Caldarella Joseph CSVP & Controller 2016-05-16Sell3,519$72.47-21.95view
LEUNG SANDRAEVP, General Counsel 2016-05-06Sell72,544$70.39-19.65view
ANDREOTTI LAMBERTODirector 2016-05-05Sell23,200$70.54-19.82view
Caforio GiovanniCEO 2016-05-03Sell34,594$71.31-20.68view

Press Releases about BMY :

Quarterly/Annual Reports about BMY:

News about BMY:

Articles On GuruFocus.com
David Tepper Invests Heavily in Pharma in 4th Quarter Feb 16 2017 
Baron Funds' Fifth Avenue Growth Fund Comments on Bristol-Myers Squibb Company Feb 13 2017 
Dodge & Cox Comments on Bristol-Myers Squibb Feb 01 2017 
Dodge & Cox's Stock Fund 4th Quarter Letter to Shareholders Feb 01 2017 
Is Bristol-Meyers a Buy After 39% Price Decline? Jan 29 2017 
Stocks Reach Their 3-Year Low Prices Jan 28 2017 
Manning & Napier’s Top 3 New Holdings Jan 26 2017 
52-Week Company Lows Jan 26 2017 
Biotech Stocks to Watch After Senate Drug Report Dec 27 2016 
Looking for Moat Stocks Dec 20 2016 

More From Other Websites
BMY Is Expected to See a Small Rise in Its 2017 Net Profit Margin Feb 27 2017
Exelixis Rockets On Bristol, Roche I-O Ties Following Merck-Incyte Team Feb 27 2017
Bristol-Myers Squibb Expects Modest Revenue Growth in 2017 Feb 27 2017
Cramer: Money's Being Thrown at Almost Everything in the Market Feb 27 2017
Analysts’ Recommendations for Bristol-Myers Squibb in 2017 Feb 27 2017
Why You Shouldn't Look Down On Your Depressed Colleagues Feb 27 2017
Billionaire Julian Robertson Bets Big on Technology Sector With These Stocks Feb 27 2017
[$$] VC Profile: OrbiMed Funds Novel Attacks on Cancer Feb 27 2017
Bristol-Myers Squibb to Take Part in Cowen and Company 37th Annual Global Health Care Conference Feb 27 2017
BRISTOL MYERS SQUIBB CO Files SEC form 8-K, Other Events, Financial Statements and Exhibits Feb 27 2017
Bristol-Myers Squibb Expands International Immuno-Oncology Network (II-ON) With Addition of Columbia... Feb 27 2017
Exelixis and Bristol-Myers Squibb Enter Clinical Collaboration for Late-Stage Combination Trial in... Feb 27 2017
Bristol-Myers (BMY) Up 20.5% Since Earnings Report: Can It Continue? Feb 27 2017
IBM, Apple, Amazon: Doug Kass' Views Feb 27 2017
Cramer: I'll Give You the Key to the Rally Feb 24 2017
BRISTOL MYERS SQUIBB CO Financials Feb 24 2017
Pharma Stock Roundup: Is BMY the Next Acquisition Target? Priority Review for PFE, Novartis Drugs Feb 24 2017
Final Trade: ORCL, AN & more Feb 23 2017
Merck, Roche Gouge Bristol's I-O Share After Lung Cancer Approvals Feb 23 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)